Cybin Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

238.54M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	864.00K	-	-
Mar 31, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sienna Senior Living	896.45M
dentalcorp Holdings	1.58B
Green Thumb Industries	1.64B
Extendicare	1.47B
Cronos Group	179.08M
WELL Health Technologies	990.34M
Trulieve Cannabis	1.71B
Curaleaf Holdings	1.89B

Revenue Rankings

Cybin News

2 days ago - Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - Business Wire
3 days ago - Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - Business Wire
4 days ago - Cybin to Participate in the 2025 Psychedelic Science Conference - Business Wire
12 days ago - Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder - Business Wire
24 days ago - Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 - Business Wire
26 days ago - Cybin Applauds FDA Commissioner Dr. Martin Makary's Call to Accelerate and Prioritize Research on Psychedelic Therapeutics - Business Wire
4 weeks ago - Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 - Seeking Alpha
4 weeks ago - Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder - Business Wire

More News